Articles published by Travere Therapeutics, Inc.
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2024
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at Upcoming Investor Conferences
August 06, 2024
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
July 08, 2024
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at Upcoming Investor Conferences
February 26, 2024
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
February 08, 2024
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference
February 01, 2024
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Provides Corporate Update and 2024 Outlook
January 08, 2024
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
Via GlobeNewswire
Tickers
TVTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.